secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2025-10-20T23:59:59+00:00
Accession:  0001479681-25-000085
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health Q3 prelim: cash collections up 259% YoY, patient volume +11.1%; Nasdaq extension granted
--------------------------------------------------------------------------------

- Preliminary Q3 2025 patient volume of 46,293 visits, up 11.1% vs Q3 2024.
- Cash collections for Q3 2025 surged 258.8% to $235M, driven by revenue cycle improvements.
- YTD 2025 cash collections $546M, up 176.9% vs YTD 2024; patient volume +14% to 140,135.
- Nasdaq extended deadline to Dec 12, 2025, for filing delinquent Q2 2025 10-Q.
- Company warns preliminary metrics are unaudited and subject to change upon final review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000147968125000085/0001479681-25-000085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000147968125000085/nutx-20251020.htm
  HTML page:      https://secwatch.observer/filing/0001479681-25-000085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer